Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Contemporary Incidence and Cancer Control Outcomes of Primary Neuroendocrine Prostate Cancer: A SEER Database Analysis.
Zaffuto E, Pompe R, Zanaty M, Bondarenko HD, Leyh-Bannurah SR, Moschini M, Dell'Oglio P, Gandaglia G, Fossati N, Stabile A, Zorn KC, Montorsi F, Briganti A, Karakiewicz PI. Zaffuto E, et al. Among authors: pompe r. Clin Genitourin Cancer. 2017 Oct;15(5):e793-e800. doi: 10.1016/j.clgc.2017.04.006. Epub 2017 Apr 13. Clin Genitourin Cancer. 2017. PMID: 28506524
North American Population-Based Validation of the National Comprehensive Cancer Network Practice Guideline Recommendation of Pelvic Lymphadenectomy in Contemporary Prostate Cancer.
Leyh-Bannurah SR, Budäus L, Pompe R, Zaffuto E, Briganti A, Abdollah F, Montorsi F, Schiffmann J, Menon M, Shariat SF, Fisch M, Chun F, Huland H, Graefen M, Karakiewicz PI. Leyh-Bannurah SR, et al. Among authors: pompe r. Prostate. 2017 Apr;77(5):542-548. doi: 10.1002/pros.23292. Epub 2017 Jan 17. Prostate. 2017. PMID: 28093788
Assessment of Oncological Outcomes After Radical Prostatectomy According to Preoperative and Postoperative Cancer of the Prostate Risk Assessment Scores: Results from a Large, Two-center Experience.
Leyh-Bannurah SR, Dell'Oglio P, Zaffuto E, Briganti A, Schiffmann J, Pompe RS, Tilki D, Heinzer H, Graefen M, Karakiewicz PI, Budäus L. Leyh-Bannurah SR, et al. Eur Urol Focus. 2019 Jul;5(4):568-576. doi: 10.1016/j.euf.2017.10.015. Epub 2017 Nov 10. Eur Urol Focus. 2019. PMID: 29129756
Are the Results of the Prostate Testing for Cancer and Treatment Trial Applicable to Contemporary Prostate Cancer Patients Treated with Radical Prostatectomy? Results from Two High-volume European Institutions.
Gandaglia G, Tilki D, Zaffuto E, Fossati N, Pompe RS, Dell'Oglio P, Graefen M, Montorsi F, Briganti A. Gandaglia G, et al. Eur Urol Focus. 2019 Jul;5(4):545-549. doi: 10.1016/j.euf.2017.10.013. Epub 2017 Nov 17. Eur Urol Focus. 2019. PMID: 29153885
Tumor characteristics, treatments, and oncological outcomes of prostate cancer in men aged ≤50 years: a population-based study.
Pompe RS, Smith A, Bandini M, Marchioni M, Martel T, Preisser F, Leyh-Bannurah SR, Schiffmann J, Saad F, Huland H, Graefen M, Shariat SF, Tilki D, Karakiewicz PI. Pompe RS, et al. Prostate Cancer Prostatic Dis. 2018 Apr;21(1):71-77. doi: 10.1038/s41391-017-0006-9. Epub 2018 Jan 16. Prostate Cancer Prostatic Dis. 2018. PMID: 29339806
73 results